Invest in better immunocontraception with pZP vaccine
Investment Thesis
- Proof of concept complete with over eight studies demonstrating fertility control in wildlife field trials
- Clear development pathway
- EPA approval expected by 1Q 2020
- Revenue can be generated quickly
- Positive ROI and ROE
- Commercial-ready in one year from closing on funding means cashflow can fund life-cycle management and portfolio expansion to develop vaccines for other species without need for additional dilutive funding
- For information on investing contact us
Opportunity / Unmet Need
- Immunocontraception has immediate application in control of overabundant wild horse populations and urban deer.
- Feral Cats
- Feral Dogs
- Macaques
- Wild Burros
- Feral Cattle
- Feral Camels
- Feral Hogs
Use of Proceeds and Development Plan
USE OF PROCEEDS:
- Create, standardize and validate manufacturing protocol
- Compile submission dossier for EPA
- QA:Manufacture batches to affirm antibody response and release specs
- Field testing of SpayVac immunocontraception with potential customers
- Vaccination of additional overabundant species to expand usage to a greater number of species
- Develop other immunocontraceptive vaccines for feral cats and feral dogs
- Set up long-term production facility